entertainment -WSS

entertainment

author：comprehensive 2025-09-30 00:33:57 - browse：44339

Adam's take main illustration — Molly Ferguson/STAT

The Food and Drug Administration should halt Cassava Sciences’ ongoing clinical trials in Alzheimer’s disease. That, and other thoughts on the fallout from the City University of New York investigation that raised serious doubts about the science underpinning the company’s experimental drug simufilam.

Patient safety is paramount to the FDA, so stopping Cassava’s two Phase 3 studies is the ethically correct thing to do.The FDA has the power to place clinical holds on experimental drugs when there’s evidence of an unacceptable safety risk to study participants. Simufilam doesn’t appear to be toxic. It’s not causing dangerous side effects. But study participants can also be harmed when they volunteer for a clinical trial based on false or misleading information about a drug’s potential efficacy.

The CUNY committee charged with investigating Cassava’s principal scientific collaborator, the neuroscientist Hoau-Yan Wang, could not definitively prove that Wang faked simufilam data, but that’s only because he refused to turn over original data and primary research records that the committee had requested to examine. Wang also claimed that boxes of research records relevant to the investigation were thrown away. The investigative report was first made public last week in the journal Science.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： The simple reason for the increase in autism diagnosis

entertainment

WSS

How clinical AI models' predictive power can degrade over time

European regulators recommend Amylyx's ALS drug be rejected

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

Here's how to stay safe from wildfire smoke amid reduced air quality

Peter Marks talks Operation Warp Speed for Rare Diseases

Why do we get seasonal allergies?

focus

entertainment

knowledge

BioMarin wins approval for gene therapy to treat hemophilia A

Tuskegee Airman Raymond Cassagnol dies at 102

Tori Bowie and the unacceptable rates of Black maternal death

Akero's treatment for NASH falls short in cirrhosis study

Medical records are filled with copy

Synthetic human embryos? Researchers say term is overblown

Apple is now the first public company to be valued at $3 trillion

The simple reason for the increase in autism diagnosis

Trump demands the U.S. pay no more for drugs than other countries … again

Brazil's Jair Bolsonaro is barred from running for office until 2030

focus

What's changing in Medicare's open enrollment this year?

How should state employee insurance handle Wegovy?

The simple reason for the increase in autism diagnosis

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

The simple reason for the increase in autism diagnosis

Brazil's Jair Bolsonaro is barred from running for office until 2030

focus

hotspot

entertainment

hotspot